Wei‐Ting Shen
Papers
1
Total Citations
66
H-Index
1
About
Wei-Ting Shen is a pioneering researcher in biohybrid microrobotics and gastrointestinal therapeutics, whose work bridges advanced materials science with biomedical engineering. Her most impactful contribution is the development of the "algae-MΦNP-robot," a biohybrid microrobotic system designed to treat inflammatory bowel disease (IBD). This innovative platform, detailed in her highly cited 2024 paper (66 citations), combines living microalgae with macrophage-derived nanoparticles to precisely regulate colonic cytokines and restore the epithelial barrier—offering a targeted alternative to conventional treatments that often carry significant side effects. Shen’s research addresses a critical gap in IBD therapy, where cytokine-driven inflammation remains poorly managed. Her work exemplifies how biohybrid systems can overcome the limitations of traditional drug delivery, achieving localized, dynamic therapeutic responses. By integrating biological motors with synthetic nanocarriers, Shen has opened new avenues for treating chronic inflammatory conditions. Her achievements signal a transformative shift toward intelligent, cell-inspired microrobots in medicine, positioning her as a rising leader in the field of biohybrid robotics and gastrointestinal disease intervention.
Research Focus
Key Achievements
Top Papers
- 1